sulfasalazine has been researched along with B. burgdorferi Infection in 3 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " All available evidence indicates that short term antibacterial treatment has no effect on the prognosis and final outcome of ReA, and the results with long term administration of antibacterials are also overall poor." | 2.41 | Bacteria-Triggered reactive arthritis: implications for antibacterial treatment. ( Toivanen, A, 2001) |
| "Seronegative Lyme arthritis was diagnosed based on the classic clinical manifestations and DNA-detected Borrelia garinii in blood and synovial fluid of the patient, after all other possible causes of the disease had been ruled out." | 1.31 | Seronegative Lyme arthritis caused by Borrelia garinii. ( Dejmková, H; Gatterová, J; Hulínska, D; Pavelka, K; Tegzová, D; Vavrík, P, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulteel, NS | 1 |
| Russell, CD | 1 |
| Perry, MR | 1 |
| Koch, O | 1 |
| Dejmková, H | 1 |
| Hulínska, D | 1 |
| Tegzová, D | 1 |
| Pavelka, K | 1 |
| Gatterová, J | 1 |
| Vavrík, P | 1 |
| Toivanen, A | 1 |
1 review available for sulfasalazine and B. burgdorferi Infection
| Article | Year |
|---|---|
Bacteria-Triggered reactive arthritis: implications for antibacterial treatment.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Reactive; Borrelia burgdorferi Group; Drug A | 2001 |
2 other studies available for sulfasalazine and B. burgdorferi Infection
| Article | Year |
|---|---|
Successful reintroduction of tumour necrosis factor-alpha inhibition after treatment of disseminated Lyme borreliosis.
Topics: Adult; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis; Ceftriaxone; Certolizumab Pegol; Doxy | 2019 |
Seronegative Lyme arthritis caused by Borrelia garinii.
Topics: Adult; Antigens, Bacterial; Borrelia burgdorferi Group; Ceftriaxone; Cephalosporins; DNA, Bacterial; | 2002 |